Capital International Investors reports 4.2% stake in BeOne

BeOne Medicines Ltd. ownership update: Capital International Investors filed an amendment to report beneficial ownership of 65,211,266 shares, representing 4.2% of the class based on 1,540,975,898 shares outstanding.

Rhea-AI Filing Summary

BeOne Medicines Ltd. ownership update: Capital International Investors filed an amendment to report beneficial ownership of 65,211,266 shares, representing 4.2% of the class based on 1,540,975,898 shares outstanding. The filing states CII has sole voting power over 64,349,154 shares and sole dispositive power over 65,211,266 shares. The report also notes 4,638,440 Depository Receipts that the filer says represent 60,299,720 Common Stock.

Insights

Institutional Ownership Analyst

Large passive stake disclosure: CII reports a 4.2% position in BeOne Medicines.

Capital International Investors is reporting beneficial ownership of 65,211,266 shares, with sole voting power over 64,349,154 shares. The filing classifies these holdings under the Schedule 13G/A ownership disclosure framework.

The economic significance depends on future filings and any changes to the position; subsequent amendments would reveal increases or disposals.

Equity Registrar / Corporate Actions Specialist

Shares and DRs reported together; conversion ratio appears embedded in the filing's statement.

The filing lists 4,638,440 Depository Receipts and states they "represent 60,299,720 Common Stock," an allocation noted by the filer. This phrasing should be reconciled with company records for precise DR conversion mechanics.

Registrars or transfer agents may need to confirm the DR-to-share mapping if assessing float or transfer logistics.

Key Figures

Beneficial ownership: 65,211,266 shares Percent of class: 4.2% Shares outstanding: 1,540,975,898 shares +4 more

7 metrics

Beneficial ownership 65,211,266 shares reported in Schedule 13G/A amendment

Percent of class 4.2% of 1,540,975,898 shares believed outstanding

Shares outstanding 1,540,975,898 shares figure referenced by the filer as outstanding

Sole voting power 64,349,154 shares voting power reported by CII

Sole dispositive power 65,211,266 shares dispositive power reported by CII

Depository Receipts 4,638,440 DRs reported as representing 60,299,720 Common Stock

Common stock represented by DRs 60,299,720 shares stated representation of DRs in the filing

Key Terms

Schedule 13G/A, Beneficial ownership, Depository Receipts

3 terms

Schedule 13G/A regulatory

"Amendment No. 6; filing type reporting passive beneficial ownership"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficial ownership financial

"Amount beneficially owned: 65,211,266; 4.2% of outstanding"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Depository Receipts financial

"Shares reported include 4,638,440 Depository Receipts"

A depository receipt is a tradable certificate issued by a bank that represents ownership of shares held in a foreign company, letting investors buy and sell those shares on their local stock market without dealing with the foreign exchange and custody details. Think of it as a local receipt for a piece of a foreign company kept in a secure vault abroad; it matters because it makes international investing easier, often increases liquidity, and can affect dividend payments and currency risk.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Capital International Investors report in BeOne Medicines (ONC)?

Capital International Investors reports beneficial ownership of 65,211,266 shares, equal to 4.2% of 1,540,975,898 shares believed outstanding, per the amendment.

How much voting power does CII hold in BeOne Medicines (ONC)?

CII reports sole voting power over 64,349,154 shares and shared voting power of 0, as stated in the Schedule 13G/A amendment.

What is the relationship between the Depository Receipts and common stock in the filing?

The filing lists 4,638,440 Depository Receipts and states they "represent 60,299,720 Common Stock," as reported by the filer in the amendment.

Does the filing indicate CII controls disposition of the shares?

Yes. The amendment reports CII has sole dispositive power over 65,211,266 shares and shared dispositive power of 0, per the disclosed fields.

When was the Schedule 13G/A signed and filed by the reporting person?

The signature block shows the filing was signed by Aaron Espin, Senior Vice President, dated 05/13/2026 in the amendment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/14/2026 - 12:52 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 6)

BeOne Medicines Ltd.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

H0743H114

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): H0743H114

1

Names of Reporting Persons

Capital International Investors

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 64,349,154.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 65,211,266.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

65,211,266.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.2 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: BeOne Medicines Ltd.
(b)	Address of issuer's principal executive offices: C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL 4051, Switzerland
Item 2.
(a)	Name of person filing: Capital International Investors
(b)	Address or principal business office or, if none, residence: 333 South Hope Street, 55th Fl, Los Angeles, CA 90071
(c)	Citizenship: N/A
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: H0743H114
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 65,211,266 ** **Capital International Investors ("CII") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CII's divisions of each of the investment management entities collectively provide investment management services under the name "Capital International Investors." CII is deemed to be the beneficial owner of 65,211,266 shares or 4.2% of the 1,540,975,898 shares believed to be outstanding. Shares reported include 4,638,440 Depository Receipts, which represent 60,299,720 Common Stock.
(b)	Percent of class: 4.2 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 64,349,154
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 65,211,266
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Capital International Investors

Signature:	Aaron Espin
Name/Title:	Senior Vice President
Date:	05/13/2026